Insights
Strengthening BLA Programs Through Proactive Risk Planning
Introduction Life sciences programs face evolving regulatory risks at every stage from preclinical IND filings to global CTA submissions, and through NDA or BLA approvals.
Leadership Roles in FDA Inspection Preparation and Mock Audits
For life sciences organizations, FDA inspections are high-stakes events that test every aspect of operations, from documentation and processes to staff readiness. Mock FDA audits
FDA Inspection Preparation Checklist for Pharma and Biotech
For pharmaceutical and biopharma companies, FDA inspections are critical checkpoints in the journey toward regulatory approval. New Drug Applications (NDAs) require meticulous preparation to ensure
Common IDE Submission Deficiencies and How to Avoid Them
For medical device companies seeking to conduct clinical trials in the United States, an Investigational Device Exemption (IDE) application is essential. A well-prepared IDE submission
Best Practices to Speed Up FDA IDE Review Process
For medical device sponsors, timely Investigational Device Exemption (IDE) submission and approval is critical to initiating clinical trials and advancing product development. Delays in IDE
Aligning eQMS Configuration with Regulatory Data Integrity Requirements
Ensuring Compliance with Electronic QMS Solutions In the Pharmaceutical, Biotech, and Medical device industries, maintaining data integrity and traceability is critical for regulatory compliance and operational efficiency. A validated electronic Quality Management System (eQMS) provides